Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
Authors
Keywords
Cancer, Chemotherapy, RNA modification, m, A RNA modification, Drug resistance, Surmounting chemoresistance
Journal
DRUG RESISTANCE UPDATES
Volume 53, Issue -, Pages 100720
Publisher
Elsevier BV
Online
2020-08-21
DOI
10.1016/j.drup.2020.100720
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG
- (2020) Omprakash Shriwas et al. APOPTOSIS
- The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB
- (2020) Sasithorn Wanna-udom et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Targeting complex, adaptive responses in melanoma therapy
- (2020) Phil Cheng et al. CANCER TREATMENT REVIEWS
- Linking m 6 A to Wnt signaling
- (2020) Xiao‐Min Liu et al. EMBO REPORTS
- FTO promotes cell proliferation and migration in esophageal squamous cell carcinoma through up-regulation of MMP13
- (2020) Shenxiang Liu et al. EXPERIMENTAL CELL RESEARCH
- RNA m 6 A methylation regulates uveal melanoma cell proliferation, migration, and invasion by targeting c‐Met
- (2020) Guangying Luo et al. JOURNAL OF CELLULAR PHYSIOLOGY
- TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1
- (2020) Jie Su et al. NATURE
- N6-Methyladenosine Regulates the Expression and Secretion of TGFβ1 to Affect the Epithelial–Mesenchymal Transition of Cancer Cells
- (2020) Jiexin Li et al. Cells
- Extrachromosomal DNA—relieving heredity constraints, accelerating tumour evolution
- (2020) C. Bailey et al. ANNALS OF ONCOLOGY
- Acquired Resistance to Immune Checkpoint Inhibitors
- (2020) Adam J. Schoenfeld et al. CANCER CELL
- m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
- (2020) Huilin Huang et al. CANCER CELL
- N6-methyladenosine demethylase FTO promotes M1 and M2 macrophage activation
- (2020) Xiaofei Gu et al. CELLULAR SIGNALLING
- Long non-coding RNAs as a determinant of cancer drug resistance: Towards the overcoming of chemoresistance via modulation of lncRNAs
- (2020) Wenxiao Jiang et al. DRUG RESISTANCE UPDATES
- Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors
- (2020) Sabrina Dallavalle et al. DRUG RESISTANCE UPDATES
- Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia
- (2020) Luyao Long et al. DRUG RESISTANCE UPDATES
- RNA m 6 A methylation regulates sorafenib resistance in liver cancer through FOXO 3‐mediated autophagy
- (2020) Ziyou Lin et al. EMBO JOURNAL
- Downregulation of METTL14 increases apoptosis and autophagy induced by cisplatin in pancreatic cancer cells
- (2020) Fanhua Kong et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- MP17-01 CIRCMORC3 CONTRIBUTES TO CISPLATIN-RESISTANCE BY AFFECTING M6A MODIFICATION ON DNA DAMAGE RESPONSE RELATED GENES IN BLADDER CANCER
- (2020) Yinjie Su* et al. JOURNAL OF UROLOGY
- Targeting apoptosis in cancer therapy
- (2020) Benedito A. Carneiro et al. Nature Reviews Clinical Oncology
- TRIM11 facilitates chemoresistance in nasopharyngeal carcinoma by activating the β-catenin/ABCC9 axis via p62-selective autophagic degradation of Daple
- (2020) Runa Zhang et al. Oncogenesis
- Recent Patents on the Development of c-Met Kinase Inhibitors
- (2020) Xiangming Xu et al. Recent Patents on Anti-Cancer Drug Discovery
- Can CYP Inhibition Overcome Chemotherapy Resistance?
- (2020) Magnus Ingelman-Sundberg et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Corrigendum to “Dexmedetomidine Postconditioning Alleviates Hypoxia/Reoxygenation Injury in Senescent Myocardial Cells by Regulating lncRNA H19 and m6A Modification”
- (2020) Xuan Zhang et al. Oxidative Medicine and Cellular Longevity
- Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
- (2020) Nuray Erin et al. DRUG RESISTANCE UPDATES
- Cancer immunotherapy resistance based on immune checkpoints inhibitors: Targets, biomarkers, and remedies
- (2020) Elisabeth Pérez-Ruiz et al. DRUG RESISTANCE UPDATES
- p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cells
- (2019) Luciana P. Rangel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Activation of EGFR-DNA-PKcs pathway by IGFBP2 protects esophageal adenocarcinoma cells from acidic bile salts-induced DNA damage
- (2019) Zhangjian Zhou et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Discovery of Small Molecules that Activate RNA Methylation through Cooperative Binding to the METTL3-14-WTAP Complex Active Site
- (2019) Simona Selberg et al. Cell Reports
- Principles of Resistance to Targeted Cancer Therapy: Lessons from Basic and Translational Cancer Biology
- (2019) Amit J. Sabnis et al. TRENDS IN MOLECULAR MEDICINE
- RNA m6A methyltransferase METTL3 regulates invasiveness of melanoma cells by matrix metallopeptidase 2
- (2019) Ujwal Dahal et al. MELANOMA RESEARCH
- EGF receptor and PKCδ kinase activate DNA damage–induced pro-survival and pro-apoptotic signaling via biphasic activation of ERK and MSK1 kinases
- (2019) Angela M. Ohm et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A DNA Repair and Cell-Cycle Gene Expression Signature in Primary and Recurrent Glioblastoma: Prognostic Value and Clinical Implications
- (2019) Matthieu Gobin et al. CANCER RESEARCH
- Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance
- (2019) Jonathan Cooper et al. CANCER CELL
- METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes
- (2019) Huiwen Song et al. Autophagy
- Small-Molecule Targeting of Oncogenic FTO Demethylase in Acute Myeloid Leukemia
- (2019) Yue Huang et al. CANCER CELL
- Moving From Poly (ADP-Ribose) Polymerase Inhibition to Targeting DNA Repair and DNA Damage Response in Cancer Therapy
- (2019) Charlie Gourley et al. JOURNAL OF CLINICAL ONCOLOGY
- ALKBH5 inhibited autophagy of epithelial ovarian cancer through miR-7 and BCL-2
- (2019) Hongtao Zhu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment
- (2019) Yidi Qu et al. Molecular Cancer
- Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers
- (2019) Hailing Shi et al. MOLECULAR CELL
- Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1
- (2019) Shiming Peng et al. Science Translational Medicine
- Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation
- (2019) Huamin Wang et al. Nature Communications
- METTL3/m6A/miRNA-873-5p Attenuated Oxidative Stress and Apoptosis in Colistin-Induced Kidney Injury by Modulating Keap1/Nrf2 Pathway
- (2019) Jian Wang et al. Frontiers in Pharmacology
- YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma
- (2019) Yang Bai et al. Frontiers in Oncology
- Cancer treatment and survivorship statistics, 2019
- (2019) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Long non-coding RNA FAM225A promotes nasopharyngeal carcinoma tumorigenesis and metastasis by acting as ceRNA to sponge miR-590-3p/miR-1275 and upregulate ITGB3
- (2019) Zi-Qi Zheng et al. CANCER RESEARCH
- Exosomes and their role in tumorigenesis and anticancer drug resistance
- (2019) Neta Milman et al. DRUG RESISTANCE UPDATES
- Immune checkpoint inhibitor combinations: Current efforts and important aspects for success
- (2019) Edo Kon et al. DRUG RESISTANCE UPDATES
- Microenvironment plasticity confers cetuximab resistance
- (2019) Peter Sidaway Nature Reviews Clinical Oncology
- Integrins as biomechanical sensors of the microenvironment
- (2019) Jenny Z. Kechagia et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The roles of DNA, RNA and histone methylation in ageing and cancer
- (2019) Ewa M. Michalak et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade
- (2019) Seungwon Yang et al. Nature Communications
- Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer
- (2019) Cheng Zhang et al. Cancer Medicine
- A Review in Research Progress Concerning m6A Methylation and Immunoregulation
- (2019) Caiyan Zhang et al. Frontiers in Immunology
- The multi-factorial nature of clinical multidrug resistance in cancer
- (2019) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer
- (2019) Alessandro Leonetti et al. DRUG RESISTANCE UPDATES
- N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2
- (2019) Hong Wang et al. GENE
- ANKLE1 N 6 ‐Methyladenosine‐related variant is associated with colorectal cancer risk by maintaining the genomic stability
- (2019) Jianbo Tian et al. INTERNATIONAL JOURNAL OF CANCER
- Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway
- (2019) Wen Peng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Reading, writing and erasing mRNA methylation
- (2019) Sara Zaccara et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The RNA m6A methyltransferase METTL3 promotes pancreatic cancer cell proliferation and invasion
- (2019) Tianfang Xia et al. PATHOLOGY RESEARCH AND PRACTICE
- Overcoming adaptive therapy resistance in AML by targeting immune response pathways
- (2019) Katelyn Melgar et al. Science Translational Medicine
- m6A RNA Methylation Maintains Hematopoietic Stem Cell Identity and Symmetric Commitment
- (2019) Yuanming Cheng et al. Cell Reports
- N6-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer
- (2019) Huan Jin et al. EBioMedicine
- The m6A methyltransferase METTL3 cooperates with demethylase ALKBH5 to regulate osteogenic differentiation through NF-κB signaling
- (2019) Jinjin Yu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Regulation of Co-transcriptional Pre-mRNA Splicing by m6A through the Low-Complexity Protein hnRNPG
- (2019) Katherine I. Zhou et al. MOLECULAR CELL
- Wnt signaling and drug resistance in cancer
- (2019) Zheng Zhong et al. MOLECULAR PHARMACOLOGY
- Dissecting the m6A methylation affection on afatinib resistance in non-small cell lung cancer
- (2019) Qianqian Meng et al. PHARMACOGENOMICS JOURNAL
- Nrf2: Redox and Metabolic Regulator of Stem Cell State and Function
- (2019) Xiaozhen Dai et al. TRENDS IN MOLECULAR MEDICINE
- RNA m6A Methyltransferase METTL3 Promotes The Growth Of Prostate Cancer By Regulating Hedgehog Pathway
- (2019) Jiarong Cai et al. OncoTargets and Therapy
- Integrated analysis of transcriptome-wide m6A methylome of osteosarcoma stem cells enriched by chemotherapy
- (2019) Yongjie Wang et al. Epigenomics
- YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression
- (2019) Yulin Shi et al. Nature Communications
- Long-noncoding RNAs (lncRNAs) in drug metabolism and disposition, implications in cancer chemo-resistance
- (2019) Yue Wang et al. Acta Pharmaceutica Sinica B
- Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells
- (2019) Marco Tucci et al. Frontiers in Oncology
- Methylation of adenosine at the N6 position post-transcriptionally regulates hepatic P450s expression
- (2019) Masataka Nakano et al. BIOCHEMICAL PHARMACOLOGY
- 3D proteome-wide scale screening and activity evaluation of a new ALKBH5 inhibitor in U87 glioblastoma cell line
- (2019) Alessio Malacrida et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Towards the overcoming of anticancer drug resistance mediated by p53 mutations
- (2019) Xin Cao et al. DRUG RESISTANCE UPDATES
- Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance
- (2019) Silpa Narayanan et al. DRUG RESISTANCE UPDATES
- Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance
- (2019) M. Helena Vasconcelos et al. DRUG RESISTANCE UPDATES
- m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
- (2019) Dan Jin et al. Journal of Hematology & Oncology
- Restoration of conformation of mutant p53
- (2018) J A Green et al. ANNALS OF ONCOLOGY
- R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m 6 A/MYC/CEBPA Signaling
- (2018) Rui Su et al. CELL
- m6A mRNA methylation sustains Treg suppressive functions
- (2018) Jiyu Tong et al. CELL RESEARCH
- METTL14 Inhibits Hematopoietic Stem/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m 6 A Modification
- (2018) Hengyou Weng et al. Cell Stem Cell
- Methylation of RNA N 6 -methyladenosine in modulation of cytokine responses and tumorigenesis
- (2018) Guoqiang Chang et al. CYTOKINE
- How mutations shape p53 interactions with the genome to promote tumorigenesis and drug resistance
- (2018) Thorsten Stiewe et al. DRUG RESISTANCE UPDATES
- Redundant angiogenic signaling and tumor drug resistance
- (2018) Rajesh N. Gacche et al. DRUG RESISTANCE UPDATES
- The complex relationship between TFEB transcription factor phosphorylation and subcellular localization
- (2018) Rosa Puertollano et al. EMBO JOURNAL
- Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR -Mutated NSCLC
- (2018) Roberta Minari et al. Journal of Thoracic Oncology
- FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting β-catenin through mRNA demethylation
- (2018) Shun Zhou et al. MOLECULAR CARCINOGENESIS
- Zc3h13 Regulates Nuclear RNA m 6 A Methylation and Mouse Embryonic Stem Cell Self-Renewal
- (2018) Jing Wen et al. MOLECULAR CELL
- Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation
- (2018) Huilin Huang et al. NATURE CELL BIOLOGY
- Understanding the tumor immune microenvironment (TIME) for effective therapy
- (2018) Mikhail Binnewies et al. NATURE MEDICINE
- cAMP-independent non-pigmentary actions of variant melanocortin 1 receptor: AKT-mediated activation of protective responses to oxidative DNA damage
- (2018) María Castejón-Griñán et al. ONCOGENE
- The m6A reader protein YTHDC2 interacts with the small ribosomal subunit and the 5′-3′ exoribonuclease XRN1
- (2018) Jens Kretschmer et al. RNA
- Amazing Diversity in Biochemical Roles of Fe(II)/2-Oxoglutarate Oxygenases
- (2018) Caitlyn Q Herr et al. TRENDS IN BIOCHEMICAL SCIENCES
- APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
- (2018) Qiang Zhang et al. Cell Death & Disease
- Molecular basis for the specific and multivariant recognitions of RNA substrates by human hnRNP A2/B1
- (2018) Baixing Wu et al. Nature Communications
- LEM-3 is a midbody-tethered DNA nuclease that resolves chromatin bridges during late mitosis
- (2018) Ye Hong et al. Nature Communications
- N 6 -methyladenosine modification: a novel pharmacological target for anti-cancer drug development
- (2018) Yi Niu et al. Acta Pharmaceutica Sinica B
- m6A RNA modification controls autophagy through upregulating ULK1 protein abundance
- (2018) Shouheng Jin et al. CELL RESEARCH
- Loss of YTHDF2-mediated m6A-dependent mRNA clearance facilitates hematopoietic stem cell regeneration
- (2018) Hu Wang et al. CELL RESEARCH
- Identification of Natural Compound Radicicol as a Potent FTO Inhibitor
- (2018) Ruiyong Wang et al. MOLECULAR PHARMACEUTICS
- m6A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer
- (2018) Jun Liu et al. NATURE CELL BIOLOGY
- Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M–Positive Lung Cancer and Acquired Resistance to Osimertinib
- (2018) Geoffrey R. Oxnard et al. JAMA Oncology
- A dynamic N6-methyladenosine methylome regulates intrinsic and acquired resistance to tyrosine kinase inhibitors
- (2018) Fei Yan et al. CELL RESEARCH
- MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: Current implications and future directions
- (2018) Alessandro Leonetti et al. DRUG RESISTANCE UPDATES
- Modulating ROS to overcome multidrug resistance in cancer
- (2018) Qingbin Cui et al. DRUG RESISTANCE UPDATES
- Chromatin regulatory mechanisms and therapeutic opportunities in cancer
- (2018) Alfredo M. Valencia et al. NATURE CELL BIOLOGY
- Acquired HER2 mutations in ER+ metastatic breast cancer confer resistance to estrogen receptor–directed therapies
- (2018) Utthara Nayar et al. NATURE GENETICS
- m6A modification controls the innate immune response to infection by targeting type I interferons
- (2018) Roni Winkler et al. NATURE IMMUNOLOGY
- Cancer immunoediting and resistance to T cell-based immunotherapy
- (2018) Jake S. O’Donnell et al. Nature Reviews Clinical Oncology
- Clinical epigenetics: seizing opportunities for translation
- (2018) María Berdasco et al. NATURE REVIEWS GENETICS
- Therapy resistance mediated by cancer stem cells
- (2018) Teresa Bernadette Steinbichler et al. SEMINARS IN CANCER BIOLOGY
- Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity
- (2018) Benny Zhitomirsky et al. Cell Death & Disease
- ABCC10 Plays a Significant Role in the Transport of Gefitinib and Contributes to Acquired Resistance to Gefitinib in NSCLC
- (2018) Hongbo Zhao et al. Frontiers in Pharmacology
- Lysosomal Sequestration Impairs the Activity of the Preclinical FGFR Inhibitor PD173074
- (2018) Bernhard Englinger et al. Cells
- YTHDF2 suppresses cell proliferation and growth via destabilizing the EGFR mRNA in hepatocellular carcinoma
- (2018) Li Zhong et al. CANCER LETTERS
- An N-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells
- (2018) Mohammad B. Uddin et al. BIOCHEMICAL PHARMACOLOGY
- MicroRNA-145 ModulatesN6-Methyladenosine Levels by Targeting the 3′-Untranslated mRNA Region of theN6-Methyladenosine Binding YTH Domain Family 2 Protein
- (2017) Zhe Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Drugging the Cancers Addicted to DNA Repair
- (2017) Jac A. Nickoloff et al. JNCI-Journal of the National Cancer Institute
- The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer
- (2017) Pingting Zhou et al. Molecular Cancer
- METCopy Number Gain Is Associated with Gefitinib Resistance in Leptomeningeal Carcinomatosis ofEGFR-mutant Lung Cancer
- (2017) Shigeki Nanjo et al. MOLECULAR CANCER THERAPEUTICS
- m6A mRNA methylation controls T cell homeostasis by targeting the IL-7/STAT5/SOCS pathways
- (2017) Hua-Bing Li et al. NATURE
- RNA m6A methylation regulates the ultraviolet-induced DNA damage response
- (2017) Yang Xiang et al. NATURE
- Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
- (2017) Christopher Abbosh et al. NATURE
- RAD6 promotes DNA repair and stem cell signaling in ovarian cancer and is a promising therapeutic target to prevent and treat acquired chemoresistance
- (2017) R R Somasagara et al. ONCOGENE
- Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance
- (2017) A Visvanathan et al. ONCOGENE
- New strategies for targeting drug combinations to overcome mutation-driven drug resistance
- (2017) Linyan Wang et al. SEMINARS IN CANCER BIOLOGY
- m 6 A in mRNA: An Ancient Mechanism for Fine-Tuning Gene Expression
- (2017) Jean-Yves Roignant et al. TRENDS IN GENETICS
- A sequential EMT-MET mechanism drives the differentiation of human embryonic stem cells towards hepatocytes
- (2017) Qiuhong Li et al. Nature Communications
- Reduced m6A mRNA methylation is correlated with the progression of human cervical cancer
- (2017) Xiuli Wang et al. Oncotarget
- The M6A methyltransferase METTL3: acting as a tumor suppressor in renal cell carcinoma
- (2017) Xiao Li et al. Oncotarget
- Genome-Wide Maps of m6A circRNAs Identify Widespread and Cell-Type-Specific Methylation Patterns that Are Distinct from mRNAs
- (2017) Chan Zhou et al. Cell Reports
- m 6 A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells
- (2017) Qi Cui et al. Cell Reports
- The conserved RNA helicase YTHDC2 regulates the transition from proliferation to differentiation in the germline
- (2017) Alexis S Bailey et al. eLife
- YTHDC1 mediates nuclear export of N6-methyladenosine methylated mRNAs
- (2017) Ian A Roundtree et al. eLife
- Drugging the Cancers Addicted to DNA Repair
- (2017) Jac A. Nickoloff et al. JNCI-Journal of the National Cancer Institute
- Targeting autophagy to overcome chemoresistance in acute myleogenous leukemia
- (2016) Sujan Piya et al. Autophagy
- A Novel Inhibitor of the Obesity-Related Protein FTO
- (2016) Yan Qiao et al. BIOCHEMISTRY
- Tumor microenvironment and cancer therapy resistance
- (2016) Yu Sun CANCER LETTERS
- Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade
- (2016) Zhaolin Chen et al. CANCER LETTERS
- Heterogeneous Mechanisms of Primary and Acquired Resistance to Third-Generation EGFR Inhibitors
- (2016) S. Ortiz-Cuaran et al. CLINICAL CANCER RESEARCH
- Repositioning of drugs for intervention in tumor progression and metastasis: Old drugs for new targets
- (2016) Giridhar Mudduluru et al. DRUG RESISTANCE UPDATES
- Folylpoly-γ-glutamate synthetase: A key determinant of folate homeostasis and antifolate resistance in cancer
- (2016) Shachar Raz et al. DRUG RESISTANCE UPDATES
- Old drugs, novel ways out: Drug resistance toward cytotoxic chemotherapeutics
- (2016) Ruud H. Wijdeven et al. DRUG RESISTANCE UPDATES
- Lysosomes as mediators of drug resistance in cancer
- (2016) Benny Zhitomirsky et al. DRUG RESISTANCE UPDATES
- Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies
- (2016) Wen Li et al. DRUG RESISTANCE UPDATES
- Transporter effects on cell permeability in drug delivery
- (2016) Abhirup Mandal et al. Expert Opinion on Drug Delivery
- Cancer stem cells
- (2016) Jenny C. Chang MEDICINE
- Nuclear m 6 A Reader YTHDC1 Regulates mRNA Splicing
- (2016) Wen Xiao et al. MOLECULAR CELL
- The m 6 A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells
- (2016) Shuibin Lin et al. MOLECULAR CELL
- Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study
- (2016) Marina Senek et al. MOVEMENT DISORDERS
- CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma
- (2016) Elisa M Noll et al. NATURE MEDICINE
- A framework for understanding and targeting residual disease in oncogene-driven solid cancers
- (2016) Trever G Bivona et al. NATURE MEDICINE
- Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m6A-demethylation of NANOG mRNA
- (2016) Chuanzhao Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- N6-Methyladenosine Methyltransferases and Demethylases: New Regulators of Stem Cell Pluripotency and Differentiation
- (2016) Yunshu Wu et al. STEM CELLS AND DEVELOPMENT
- Histone Modifications and Cancer
- (2016) James E. Audia et al. Cold Spring Harbor Perspectives in Biology
- p53 in the DNA-Damage-Repair Process
- (2016) Ashley B. Williams et al. Cold Spring Harbor Perspectives in Medicine
- Genetic and Pharmacological Screens Converge in Identifying FLIP, BCL2, and IAP Proteins as Key Regulators of Sensitivity to the TRAIL-Inducing Anticancer Agent ONC201/TIC10
- (2015) J. E. Allen et al. CANCER RESEARCH
- N6-methyladenosine Modulates Messenger RNA Translation Efficiency
- (2015) Xiao Wang et al. CELL
- m6A RNA Methylation Is Regulated by MicroRNAs and Promotes Reprogramming to Pluripotency
- (2015) Tong Chen et al. Cell Stem Cell
- Coordination of m 6 A mRNA Methylation and Gene Transcription by ZFP217 Regulates Pluripotency and Reprogramming
- (2015) Francesca Aguilo et al. Cell Stem Cell
- Molecular basis of resistance to proteasome inhibitors in hematological malignancies
- (2015) Denise Niewerth et al. DRUG RESISTANCE UPDATES
- The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
- (2015) Rishil J. Kathawala et al. DRUG RESISTANCE UPDATES
- Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure
- (2015) R. Pagliarini et al. EMBO REPORTS
- Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism
- (2015) Helena Joyce et al. Expert Opinion on Drug Metabolism & Toxicology
- Identification of A Novel Small-Molecule Binding Site of the Fat Mass and Obesity Associated Protein (FTO)
- (2015) Wu He et al. JOURNAL OF MEDICINAL CHEMISTRY
- eIF3 targets cell-proliferation messenger RNAs for translational activation or repression
- (2015) Amy S. Y. Lee et al. NATURE
- N6-methyladenosine-dependent RNA structural switches regulate RNA–protein interactions
- (2015) Nian Liu et al. NATURE
- m6A mRNA methylation facilitates resolution of naïve pluripotency toward differentiation
- (2015) Shay Geula et al. SCIENCE
- Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance
- (2015) Laetitia Seguin et al. TRENDS IN CELL BIOLOGY
- HNRNPC as a candidate biomarker for chemoresistance in gastric cancer
- (2015) Hao Huang et al. TUMOR BIOLOGY
- A strategy based on nucleotide specificity leads to a subfamily-selective and cell-active inhibitor of N6-methyladenosine demethylase FTO
- (2015) Joel D. W. Toh et al. Chemical Science
- Anti-inflammatory drugs and uterine cervical cancer cells: Antineoplastic effect of meclofenamic acid
- (2015) ALEJANDRO D. SORIANO-HERNANDEZ et al. Oncology Letters
- Lysosomal sequestration of hydrophobic weak base chemotherapeutics triggers lysosomal biogenesis and lysosome-dependent cancer multidrug resistance
- (2015) Benny Zhitomirsky et al. Oncotarget
- Synthesis of a FTO Inhibitor with Anticonvulsant Activity
- (2014) Guanqun Zheng et al. ACS Chemical Neuroscience
- m6A RNA Modification Controls Cell Fate Transition in Mammalian Embryonic Stem Cells
- (2014) Pedro J. Batista et al. Cell Stem Cell
- Structures of Human ALKBH5 Demethylase Reveal a Unique Binding Mode for Specific Single-strandedN6-Methyladenosine RNA Demethylation
- (2014) Chao Xu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Masitinib Antagonizes ATP-Binding Cassette Subfamily C Member 10-Mediated Paclitaxel Resistance: A Preclinical Study
- (2014) R. J. Kathawala et al. MOLECULAR CANCER THERAPEUTICS
- Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5
- (2014) Yue Huang et al. NUCLEIC ACIDS RESEARCH
- Contributions of DNA repair, cell cycle checkpoints and cell death to suppressing the DNA damage-induced tumorigenic behavior of Drosophila epithelial cells
- (2014) A Dekanty et al. ONCOGENE
- Rationally designed nanovehicles to overcome cancer chemoresistance
- (2013) Yoav D. Livney et al. ADVANCED DRUG DELIVERY REVIEWS
- N6-methyladenosine-dependent regulation of messenger RNA stability
- (2013) Xiao Wang et al. NATURE
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Targeting the BRAF V600E Mutation in Multiple Myeloma
- (2013) M. Andrulis et al. Cancer Discovery
- Acquired Resistance and Clonal Evolution in Melanoma during BRAF Inhibitor Therapy
- (2013) H. Shi et al. Cancer Discovery
- Recent advances regarding the role of ABC subfamily C member 10 (ABCC10) in the efflux of antitumor drugs
- (2013) Rishil J. Kathawala et al. Chinese Journal of Cancer
- From tumor prevention to therapy: Empowering p53 to fight back
- (2012) Christian Frezza et al. DRUG RESISTANCE UPDATES
- Antifolates in cancer therapy: Structure, activity and mechanisms of drug resistance
- (2012) Nitzan Gonen et al. DRUG RESISTANCE UPDATES
- Development of Cell-Active N6-Methyladenosine RNA Demethylase FTO Inhibitor
- (2012) Baoen Chen et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Into the Eye of the Cytokine Storm
- (2012) J. R. Tisoncik et al. MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
- Akt Promotes Post-Irradiation Survival of Human Tumor Cells through Initiation, Progression, and Termination of DNA-PKcs-Dependent DNA Double-Strand Break Repair
- (2012) M. Toulany et al. MOLECULAR CANCER RESEARCH
- ALKBH5 Is a Mammalian RNA Demethylase that Impacts RNA Metabolism and Mouse Fertility
- (2012) Guanqun Zheng et al. MOLECULAR CELL
- Overcoming Multidrug Resistance via Photodestruction of ABCG2-Rich Extracellular Vesicles Sequestering Photosensitive Chemotherapeutics
- (2012) Vicky Goler-Baron et al. PLoS One
- Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers
- (2012) Y Adar et al. Cell Death & Disease
- Lysosomal Sequestration of Sunitinib: A Novel Mechanism of Drug Resistance
- (2011) K. J. Gotink et al. CLINICAL CANCER RESEARCH
- Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
- (2011) Alina Shapira et al. DRUG RESISTANCE UPDATES
- Antitumor effect of meclofenamic acid on human androgen-independent prostate cancer: a preclinical evaluation
- (2011) Alejandro D. Soriano-Hernández et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- The Epstein–Barr virus nuclear antigen-1 promotes telomere dysfunction via induction of oxidative stress
- (2011) S A Kamranvar et al. LEUKEMIA
- N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
- (2011) Guifang Jia et al. Nature Chemical Biology
- DNA double-strand break – induced pro-survival signaling
- (2011) Amy J. Hawkins et al. RADIOTHERAPY AND ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started